Neuronetics, Inc. (STIM)
USD 1.37
(5.38%)
USD 1.37
(5.38%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.05 USD | 28.08% |
| 2022 | -1.46 USD | -4.29% |
| 2021 | -1.40 USD | 18.13% |
| 2020 | -1.71 USD | 8.56% |
| 2019 | -1.87 USD | 30.48% |
| 2018 | -2.69 USD | 99.81% |
| 2017 | -1431.28 USD | -42.95% |
| 2016 | -1001.25 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.33 USD | -22.22% |
| 2024 Q1 | -0.27 USD | -42.11% |
| 2023 Q3 | -0.33 USD | -94.12% |
| 2023 FY | - USD | 28.08% |
| 2023 Q1 | -0.40 USD | -21.21% |
| 2023 Q2 | -0.17 USD | 57.5% |
| 2023 Q4 | -0.19 USD | 42.42% |
| 2022 Q3 | -0.29 USD | 25.64% |
| 2022 FY | - USD | -4.29% |
| 2022 Q1 | -0.44 USD | -51.72% |
| 2022 Q2 | -0.39 USD | 11.36% |
| 2022 Q4 | -0.33 USD | -13.79% |
| 2021 Q1 | -0.31 USD | -63.16% |
| 2021 Q4 | -0.29 USD | 6.45% |
| 2021 Q3 | -0.31 USD | -6.9% |
| 2021 Q2 | -0.29 USD | 6.45% |
| 2021 FY | - USD | 18.13% |
| 2020 Q4 | -0.19 USD | -5.56% |
| 2020 Q2 | -0.41 USD | 39.71% |
| 2020 Q3 | -0.18 USD | 56.1% |
| 2020 FY | - USD | 8.56% |
| 2020 Q1 | -0.68 USD | -65.85% |
| 2019 FY | - USD | 30.48% |
| 2019 Q4 | -0.41 USD | -10.81% |
| 2019 Q3 | -0.37 USD | 5.13% |
| 2019 Q2 | -0.39 USD | 7.14% |
| 2019 Q1 | -0.42 USD | -20.0% |
| 2018 Q4 | -0.35 USD | -20.69% |
| 2018 FY | - USD | 99.81% |
| 2018 Q3 | -0.29 USD | 99.05% |
| 2018 Q2 | -30.60 USD | -9172.73% |
| 2018 Q1 | -0.33 USD | 99.92% |
| 2017 FY | - USD | -42.95% |
| 2017 Q1 | -402.32 USD | 0.0% |
| 2017 Q4 | -438.86 USD | -31.2% |
| 2017 Q3 | -334.49 USD | -30.86% |
| 2017 Q2 | -255.61 USD | 36.47% |
| 2016 FY | - USD | 0.0% |